Clinical Trial Update: Clinical Trial Comparing Induction Treatment With EGFR-ADC MRG003 Alone or in Combination With the Anti PD1 Pucotenlimab, Followed by Radiochemotherapy in Locally Advanced Squamous Cell Cancers of the Head and Neck [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating induction treatment with EGFR-ADC MRG003 alone or in combination with the anti-PD1 pucotenlimab, followed by radiochemotherapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• MRG003
• Pucotenlimab

Snippet

Sponsor: Groupe Oncologie Radiotherapie Tete et Cou | Conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING